Sichuan Biokin Pharmaceutical Co.,Ltd. (SHA:688506)
China · Delayed Price · Currency is CNY 375.30
+12.45 (3.43%)
At close: Sep 30, 2025
SHA:688506 Market Cap
SHA:688506 has a market cap or net worth of 150.50 billion as of October 2, 2025. Its market cap has increased by 132.73% in one year.
Market Cap
150.50B
Enterprise Value
148.10B
Revenue
441.19M
Ranking
n/a
PE Ratio
n/a
Stock Price
375.30
Market Cap Chart
Since January 6, 2023, SHA:688506's market cap has increased from 12.85B to 150.50B, an increase of 1,070.98%. That is a compound annual growth rate of 145.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2025 | 150.50B | 95.74% |
| Dec 31, 2024 | 76.88B | 37.05% |
| Dec 29, 2023 | 56.10B | 336.51% |
| Jan 6, 2023 | 12.85B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 476.78B |
| WuXi AppTec | 328.32B |
| Shenzhen Mindray Bio-Medical Electronics | 297.14B |
| Shanghai United Imaging Healthcare | 124.40B |
| Zhangzhou Pientzehuang Pharmaceutical., | 118.73B |
| Aier Eye Hospital Group | 114.71B |
| Yunnan Baiyao Group Co.,Ltd | 101.26B |
| Shanghai Fosun Pharmaceutical (Group) | 75.38B |